Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats

Journal of Biochemistry and Molecular Biology

Volumn 38, Issue 5, 2005, Pages 539-544

  Montilla, Pedro ^a   Barcos, Montserrat ^b   Muñoz, Maria C ^a   Bujalance, Inmaculada ^a   Muñoz Castañeda, Juan R ^b   Tunez, Isaac ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Diabetes; Nephropathy; Oxidative stress; Red wine; Streptozotocin

Indexed keywords

ANIMALIA; RATTUS NORVEGICUS;

EID: 32644446994     PISSN: 12258687     EISSN: 12258687     Source Type: Journal    
DOI: 10.5483/bmbrep.2005.38.5.539     Document Type: Article

References (42)

1. Abdel Wahab, Y. H., O'Harte, F. P., Ratcliff, H., McClenaghan, N. H., Barnett, C. R. and Flatt P. R. (1996) Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes 45, 1489-1496.
2. Aebi, H. (1984) Catalase in vitro. Methods Enzymol. 34, 479-500.
3. Agustin, A. J., Breipohl, W., Boker, T., Lutz, J. and Spitzbas, M. (1993) Increased lipid peroxide levels and myeloperoxidase activity in the vitreous of patients suffering from proliferative diabetic retinpathy. Graefes Arch. Clin. Exp. Ophthalmol. 231, 647-650.
4. Anjaneyulu, M. and Chopra, K. (2004) Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 31, 244-248.
5. Auslander, W., Haire-Joshu, D., Houston, C., Rhee, C. W. and Williams, J. H. (2002) A controlled evaluation of staging diatary patterns to reduce the risk of diabetes in African-American women. Diabetes Care. 25, 809-814.
6. Baynes, J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes. 40, 405-412.
7. Baynes, J. W. and Thorpe, R. (1999) Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes. 38, 1-9.
8. Biessels, G. J., Bravenboer, G. and Gispen, W. H. (2004) Glucose, insulin and the brain: modulation and synaptic plasticity in health and disease: a preface. Eur. J. Pharmacol. 490, 1-4.
9. Biessels, G. J., Kappelle, A. C., Bravenboer, B., Erkelens, D. W. and Gispen, W. H. (1994) Cerebral function in diabetes mellitus. Diabetologia. 37, 643-650.
10. Biessels, G. J., van der Heide, L. P., Kamal, A., Bleys, R. L. and Gispen, W. H. (2002) Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. 44, 1-14.
11. Bradford, M. M. (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal. Biochem. 72, 248- 254.
12. 10 treatment on oxidative stress in normal and diabetic rats. J. Biochem. Mol. Toxicol. 16, 197-202.
13. Constant, J. (1997) Alcohol, ischemic heart disease and the French paradox. Coron. Artery Dis. 8, 645-649.
14. Flohé, L. and Gunzler, W. A. (1984) Assays of glutathione peroxidase. Methods Enzymol. 105, 114-121.
15. Forbes, J. M., Cooper, M. E., Oldfield, M. D. and Thomas, M. C. (2003) Role of advanced glycation end products in diabetic nephropathy. J. Am. Soc. Nephrol. 14, 254-258.
16. Gispen, W. H. and Biessels, G. J. (2000) Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23, 542-549.
17. Giugliano, D., Ceriello, A. and Paolisso, G. (1996) Oxidative stress and diabetic vascular complications. Diabetes Care. 19, 257-267.
18. Ha, H. and Kim, K. H. (1995) Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 48, 18-21.
19. Herr, R. R., Jahnke, A. D. and Argoudelis, A. D. (1967) The structure of streptozotocin. J. Am. Chem. Soc. 89, 4808-4809.
20. Hunt, J. V., Bottoms, M. A. and Mitchinson, M. J. (1993) Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation: Some fundamental differences in proposed mechanism of glucose oxidation and oxidant production. Biochem. J. 291, 259-262.
21. Hunt, J. V., Smith, C. and Wolff, S. P. (1990) Autoxidative glycosilation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes. 39, 1420-1424.
22. Hyslop, P. A., Hinshwa, D. B. and Halsey, W. H. Jr. (1988) Mechanism of oxidant-mediated cell injury: the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J. Biol. Chem. 263, 1665-1675.
23. Kakkar, R., Kalra, J. and Mantha, S. V. (1995) Prasad K. Lipid peroxidtion and activity of antioxidant enzymes in diabetic rats. Mol. Cell Biochem. 151, 113-119.
24. Maggi-Caperyon, M. F., Cases, J., Badia, E., Cristol, J. P., Rouanet, J. M., Besancon, P., Leger, C. L. and Descomps, B. (2002) A diet high in cholesterol and deficient in vitamin E induces peroxidtion but does not enhance antioxidant enzyme expression in rat liver. J. Nutr. Biochem. 13, 296-301.
25. McCall, A. L. (1992) The impact of diabetes on the CNS. Diabetes. 41, 557-570.
26. Montilla, P., Barcos, M., Muñoz, M. C., Muñoz- Castañeda, J. R., Bujalance, I. and Túnez, I. (2004) Protective effect of Montilla-Moriles appellation red wine on oxidative stress induced by streptozotocin in the rat. J. Nutr. Biohcem. 15, 688-693.
27. Montilla, P., Vargas, J., Túnez, I., Muñoz, M. C., Valdelvira, M. E. and Cabrera, E. (1998) Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J. Pineal Res. 25, 94-100.
28. Mosmann, B. and Behl, C. (2002) Antioxidants as treatment for neurodegenerative disorders. Expert Opin. Investig. Drugs. 11, 1407-1435.
29. Muñoz, M. C., Túnez, I., Porras, T. and Montilla, P. (1993) Curso evolutivo de la glucose, fructosamina y lipoperóxidos plasmáticos en ratas diabéticas por estreptozotocina. Efectos de la vitamina E. Clin. Invest. Arterioscler. 5, 114-117.
30. Oberdley, L. W. (1988) Free radicals and diabetes. Free Radic. Biol. Med. 5, 113-124.
31. Rauscher, F. M., Sanders, R. A., Watkins, J. B. (2000) Effects of new antioxidant compounds PNU-104067F and PNU-74389G on antioxidant defense in normal and diabetic rats. J. Biochem. Mol. Toxicol. 14, 189-194.
32. Ruiz, C., Alegria, A., Barbera, R., Farre, R. and Lagarda, M. J. (1994) Lipid peroxidation and antioxidant enzyme activities in patient with type-I diabetes mellitus. Scand. J. Clin. Lab. Invest. 59, 99-105.
33. Saini, H. K., Arneja, A. S. and Dhalla, N. S. (2004) Role of cholesterol in cardiovascular dysfunction. Can. J. Cardiol. 20, 333-346.
34. Sanders, R. A., Rauscher, F. M. and Watkins, J. B. (2001) Effect of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 15, 143-149.
35. Sabu, M. C., Smith, K. and Kuttan, R. (2002) Anti-ciabetic activity of green tea poolyphenols and their role in reducing oxidative stress in experimental diabetes. J. Ethnopharmacol. 83, 109-116.
36. Serrano-Martínez, M., Martínez-Losada, E., Prado-Santamaría, M., Brugarola-Brufau, C., Fenández-Jarne, E. and Martínez-González, M. A. (2004) To what extent are the effects of diet on coronary Herat disease lipid-mediated? Int. J. Cardiol. 95, 35-38.
37. Sun, Y., Oberley, L. W. and Li, Y. (1998) A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34, 479-500.
38. Szkudelski, T. (2001) The mechanism of alloxan and streptozotocin action in b-cells of the rat pancreas. Physiol. Res. 50, 536-546.
39. Tredici, G., Miloso, M., Nicolini, G., Galbiati, S., Cavalletti, G. and Bertelli, A. (1999) Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant? Drugs Exp. Clin. Res. 25, 673-680.
40. Virgili, M. and Contestabile, A. (2000) Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-reveratrol in rats. Neurosci. Lett. 281, 123-126.
41. Vessal, M., Hemmati, M. and Vasei, M. (2003) Antidiabetic effects of quercetin in streptozotocin-induced diabetic rats. Comp. Blochem. Physiol. C. 135, 357-364.
42. Wolf, S. P., Jiang, J. Y. and Hunt, J. V. (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radie. Biol. Med. 10, 339-352.